针对晚期肝细胞癌的基于免疫的组合疗法
Riccardo Carloni1,2, Simone Sabbioni1,2, Alessandro Rizzo3
1Department of Specialized, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy.
Journal of hepatocellular carcinoma
|September 13, 2023
概括
肝细胞癌 (HCC) 治疗正在使用免疫检查点抑制剂 (ICI) 取得进展. 研究重点是将ICI与其他免疫疗法 (如CAR-T细胞和疫苗) 结合起来,以获得高级HCC的更好的结果.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 免疫疗法研究 免疫疗法研究
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 在诊断时的高级HCC和手术后复发是显著的临床挑战.
研究的目的:
- 审查在先进的HCC中基于免疫的组合疗法的合理性和正在进行的临床试验.
- 探索超越免疫检查点抑制剂 (ICI) 的新兴免疫疗法策略.
主要方法:
- 审查当前文献和临床试验数据的免疫疗法对HCC.
- 专注于涉及ICI,CAR-T细胞和抗癌疫苗的组合治疗.
主要成果:
- 免疫检查点抑制剂 (ICI),如阿特佐利祖马布/贝瓦西祖马布和杜尔瓦卢马布/特梅利穆马布,已成为一线治疗方法.
- 基于ICI的组合疗法是当前研究的主要焦点.
结论:
- 组合免疫疗法代表了先进的HCC治疗的未来方向.
- 包括CAR-T细胞和疫苗在内的新策略有望改善HCC患者的治疗结果.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


